![](/imager/uploads/25960/mattt-rachel-blogrectangle_6439e647a38ed5b4d852739476ebaac9.webp)
DCVC Announcements
Zymergen used machine learning and robotic labs to modify microbes to produce novel molecules and materials, including Hyaline, a flexible bio-based film for touch-sensitive displays. Ginkgo Bioworks acquired the company in 2022.
Using AI to speed through the last mile of drug discovery
Finding precisely tuned viral vectors for gene therapy in CNS disorders
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing